首页> 外文期刊>Reproduction, fertility, and development >Radioimmunoassay of bovine placental lactogen using recombinant and native preparations: determination of fetal concentrations across gestation.
【24h】

Radioimmunoassay of bovine placental lactogen using recombinant and native preparations: determination of fetal concentrations across gestation.

机译:使用重组和天然制剂对牛胎盘乳原进行放射免疫测定:确定整个妊娠期胎儿的浓度。

获取原文
获取原文并翻译 | 示例
           

摘要

Concentrations of bovine placental lactogen (bPL) were determined in fetal plasma samples by twelve double-antibody competitive radioimmunoassay systems (RIA I-XII) based on either recombinant bPL (non-glycosylated) or native bPL (glycosylated). Both preparations were used as standard and tracer, and for primary antisera production. The minimum detection limit measured by these RIA varied from 0.02 to 0.6 ng bPL mL(-1). The coefficients of correlation of different bPL RIA systems were up to 90% (P < 0.0001) when each RIA was tested against the average values of all twelve RIA systems. All developed RIA were used to investigate the incidence of different bPL isoforms in bovine fetal serum samples (n = 71). Fetal concentrations ranged from 11.8 to 35.7 ng mL(-1) at the third month and from 1.1 to 13.5 ng mL(-1) at the ninth month of gestation. They tended to decrease with advancing gestation. In general, those RIA systems that used recombinant bPL as the standard measured higher values than those using the native bPL preparation. These differences decreased toward the end of gestation (P < 0.05), suggesting a lower rate of glycosylation. Our results provide evidence of different glycosylated isoforms of bPL in fetal serum at different gestation periods.
机译:通过十二个基于重组bPL(非糖基化)或天然bPL(糖基化)的双抗体竞争放射免疫分析系统(RIA I-XII),测定了胎儿血浆样品中牛胎盘产乳汁原(bPL)的浓度。两种制剂均用作标准品和示踪剂,并用于初级抗血清生产。这些RIA测得的最低检测限为0.02至0.6 ng bPL mL(-1)。当针对所有十二个RIA系统的平均值测试每个RIA时,不同bPL RIA系统的相关系数高达90%(P <0.0001)。所有已开发的RIA均用于研究牛胎儿血清样品中不同bPL亚型的发生率(n = 71)。胎儿在​​妊娠第三个月的浓度范围为11.8至35.7 ng mL(-1),在妊娠第九个月的浓度为1.1至13.5 ng mL(-1)。随着妊娠的发展,他们倾向于减少。通常,使用重组bPL作为标准品的RIA系统测得的值要高于使用天然bPL制剂的RIA系统。这些差异在妊娠期末减少(P <0.05),表明糖基化率较低。我们的结果提供了不同妊娠期胎儿血清中bPL不同糖基化亚型的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号